We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted......
(read more)March 20 - Hedge Funds, News - Comments
Hedge funds are known to underperform the bull markets but that’s not because they are bad at investing. Truth be told, most hedge fund managers......
(read more)January 10 - Hedge Funds, News - Comments
The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with......
(read more)December 5 - Hedge Funds, News - Comments
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on......
(read more)October 24 - Hedge Funds, News - Comments
Activist Amber Capital Locks Horns with Lagardere Over Lawsuit (Reuters) PARIS (Reuters) – Activist shareholder Amber Capital, which is being sued......
(read more)October 14 - Hedge Funds, Insider Trading - Comments
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before the Q4 market crash that the stock market is overvalued due......
(read more)June 11 - Hedge Funds, News - Comments
Is ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours......
(read more)April 29 - Hedge Funds, News - Comments
“Value has performed relatively poorly since the 2017 shift, but we believe challenges to the S&P 500’s dominance are mounting and resulting......
(read more)December 16 - Hedge Funds, News - Comments
Crispin Odey’s Comeback Gets a Boost After Hedge Fund Surges (Bloomberg) Crispin Odey, whose bearish bets led to his hedge fund suffering three successive......
(read more)October 4 - Hedge Funds, Insider Trading - Comments
Baker Bros. Advisors purchased about 1.2 million shares of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) for about $19 per share last week. Here is why the......
(read more)September 24 - Hedge Funds, Insider Trading, News - Comments
Acadia Pharmaceuticals Inc (NASDAQ:ACAD): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros......
(read more)October 17 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......
(read more)May 18 - Hedge Funds - Comments
Mott Capital Management is a long-only fund managed by Michael Kramer. The fund usually invests in stocks with a horizon of 3-5 years and seeks to provide......
(read more)December 20 - Hedge Funds, News, Tech - Comments
Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what......
(read more)November 28 - Hedge Funds, News - Comments
March Altus Capital Management is a Connecticut-based long/short equity hedge fund that primarily invests in healthcare stocks. The fund was started in......
(read more)November 15 - Hedge Funds, News - Comments
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take......
(read more)November 14 - Hedge Funds, News - Comments
Julian Baker and Felix Baker, the managers of Baker Bros. Advisors, have taken advantage of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) recently announced......
(read more)August 15 - Hedge Funds, News - Comments
U.S. stock indexes are up substantially in Friday trading, with the S&P 500 hitting record highs, driven by a surprisingly strong jobs report out......
(read more)August 5 - Earnings Report, Market Movers, News - Comments
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused......
(read more)May 7 - Hedge Fund Analysis, Hedge Funds, News - Comments
The US stocks rallied on Wednesday after the dovish comments from Federal Reserve Chairwoman Janet Yellen on Tuesday. Among the prominent stocks that......
(read more)March 30 - Market Movers, News - Comments
U.S. equities inched up on Monday after fresh data displayed that consumer spending rose marginally in February. The Commerce Department revealed that......
(read more)March 28 - Market Movers, News - Comments
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......
(read more)February 25 - Hedge Funds, News - Comments
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......
(read more)December 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
Out of thousands of stocks that are currently traded on the market, it is difficult to determine those that can really generate strong returns. Hedge......
(read more)December 2 - Hedge Funds, News - Comments
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc. (NASDAQ:NVAX), and Diamond Offshore......
(read more)November 2 - Market Movers, News - Comments
Hal Mintz‘s Sabby Capital has initiated a passive stake in Superconductor Technologies, Inc. (NASDAQ:SCON) according to a schedule 13G form filed......
(read more)March 25 - Hedge Funds, News - Comments
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) spiked nearly 18% during Tuesday’s intraday trading and hit a 52-week high of $46.48. The price action......
(read more)March 10 - Hedge Funds, News - Comments
Andreas Halvorsen‘s Viking Global is a fund with great returns over its 15-years old history. Since its foundation, Viking’s flagship fund......
(read more)December 10 - Hedge Funds, News - Comments
Small-cap picks from individual funds might provide investors with attractive investment options. In this article we will look into Andreas Halvorsen’......
(read more)June 26 - Hedge Funds, News - Comments
Julian Baker and Felix Baker’s hedge fund, Baker Bros. Advisors, has recently tweaked its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) and......
(read more)March 10 - Hedge Funds, News - Comments
Miller: No ‘extraordinary value’ left in US markets (InvestmentWeek) Legg Mason’s Bill Miller is struggling to find the ‘extraordinary......
(read more)November 29 - Hedge Funds - Comments
Should Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) investors track the following data? At the moment, there are plenty of metrics investors can use to......
(read more)September 17 - News - Comments
Blazing. Sizzling. On fire. They all describe Celgene Corporation (NASDAQ:CELG) pretty well these days. With all of the heat generated by this biotech......
(read more)September 16 - News - Comments
Is it smart to be bullish on EXACT Sciences Corporation (NASDAQ:EXAS)? In the financial world, there are a multitude of gauges shareholders can use to......
(read more)September 6 - News - Comments
Is it smart to be bullish on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)? In the eyes of many of your fellow readers, hedge funds are viewed as overrated......
(read more)September 5 - News - Comments
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial......
(read more)September 4 - News - Comments
Is Array Biopharma Inc (NASDAQ:ARRY) a good investment? At the moment, there are many methods investors can use to analyze Mr. Market. Some of the most......
(read more)August 30 - News - Comments
Healthcare is the most happening industry these days with new drugs on the line and investors injecting cash into companies with greater speculative growth......
(read more)August 3 - News - Comments
I began using Motley Fool’s CAPS as a way to disclose when I purchased and sold stocks, and my 97.2 rating showcases my last 10 months. CAPS compares......
(read more)August 2 - News - Comments
Buyout! The word gets biotech investors’ blood flowing and their hearts racing. Mere rumors that a biotech stock could get bought out can send shares......
(read more)July 17 - News - Comments
According to IBISWorld, revenue of global biotechnology companies will surge to $262 billion this year, up by 12.7%, year-over-year. This growth is due......
(read more)July 16 - News - Comments
Only a handful of stocks have gained 200% in 2013, and five of those stocks are in the biotechnology industry. Perhaps you already own one, or maybe......
(read more)July 12 - News - Comments
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has seen a decrease in hedge fund interest of late. According to most shareholders, hedge funds are seen as......
(read more)June 24 - News - Comments
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) was in 11 hedge funds’ portfolio at the end of March. OPTR investors should be aware of a decrease in......
(read more)June 12 - News - Comments
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’ 1,100% gain makes it one of the best performing stocks in the market. This rally began after its Parkinson......
(read more)June 12 - News - Comments
EXACT Sciences Corporation (NASDAQ:EXAS) investors should be aware of an increase in hedge fund sentiment lately. At the moment, there are tons of metrics......
(read more)June 10 - News - Comments
One of the best ways that retail investors can try to decide which stocks will make for a promising investment is to look at what the hedge funds are......
(read more)June 10 - Hedge Funds - Comments
